Indane derivatives as AMPA receptor modulators
US8536214B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Inventors
Key dates
| Filing date | Jun 3, 2009 |
| Grant date | Sep 17, 2013 |
| Priority date | — |
| Expiry date | Sep 4, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a heterocyclic derivative according to formula (I); wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of psychiatric diseases where an enhancement of synaptic responses mediated by AMPA receptors is required, including schizophrenia, depression and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.